5th Annual BHIVA Conference for the Management of HIV/Hepatitis Co-infection in collaboration with BASL and BVHG - Presentations

Date: Wednesday 3 October 2012

Venue: One Great George Street Conference Centre, London

Plenary Session 1

HCV mono-infection: when to treat and when to wait
Professor Stefan Zeuzem, J.W. Goethe University Hospital, Frankfurt, Germany

HIV/HCV co-infection: when to treat and when to wait
Dr Curtis Cooper, The Ottawa Hospital, Canada

Plenary Session 2

Pathogenesis of liver disease in HIV/HBV co-infection
Professor Sharon Lewin, Alfred Hospital and Monash University, Melbourne, Australia

Treating hepatitis C in patients with chronic renal disease
Dr Ashley Brown, Imperial College Healthcare NHS Trust, London


The motion: HIV-1-positive patients co-infected with hepatitis C should be excluded from liver transplant programmes

For the motion:
Professor John O'Grady, King's College Hospital, London

Against the motion:
Dr James O'Beirne, Royal Free Hospital, London

Plenary Session 3

The impact of viral resistance in the management of HCV with DAAs
Professor Stanislas Pol, University of Paris, France

Drug-drug interactions with new HCV drugs
Professor David Back, University of Liverpool

Difficult HIV/hepatitis co-infection SpR case presentation session

A case of complications
Dr Katharine Cartwright, Leicester Royal Infirmary

First do no harm...
Dr Emma O'Cofaigh, Leeds Teaching Hospitals Trust

HCV or not HCV, that is the question
Dr Beth White, NHS Greater Glasgow and Clyde